- 14 hrs ago Designer Virgil Abloh, Famous For High-End Streetwear, Passes Away At 41 From Cancer
- 16 hrs ago Omicron Reportedly Has 30+ Mutations In Spike Protein Region, May Bypass Vaccines: AIIMS Chief Randeep Guleria
- 17 hrs ago Amazon Sale: Awesome Smart And Elegant Watches For Women With Up To 60% Off
- 17 hrs ago Planning To Bleach Your Hair? 8 Things To Look Out For And A Step-By-Step Guide
- News In Parliament today: Bills to amend judges salaries on the anvil
- Movies Nushrratt Bharuccha Recalls Scary Incident At Hotel; 'When My Staff Came, They Said, ‘Ma'am We Should Leave’
- Sports Lionel Messi wins historic seventh Ballon d'Or
- Finance Small Cap Company Stock To Watch Out After Dolly Khanna Ups Stake
- Education KVPY Aptitude Test 2021 Date Announced, Check KVPY Fellowship Exam Date And Other Details Here
- Technology Oppo Reno7, Reno7 Pro India Pricing Details Out; Reno7 SE Not Coming
- Travel Discovery’s Lost Essence S2: Cyrus Sahukar Explores The Hidden Gems Of India
- Automobiles Nissan To Launch 15 New Electric Vehicles By 2030
Serum Institute of India (SII) has urged the government to fast-track the Covishield movement citing the difficulties being faced in production and cold chain space planning for other vaccines because of the increasing stock of its COVID-19 jab, official sources said on Sunday.
Prakash Kumar Singh, Director, Government and Regulatory Affairs at SII, is learnt to have recently communicated to the Union Health Ministry that it has a manufactured stock of 24,89,15,000 Covishield doses and it is increasing every day.
In addition to the Covishield vaccine, the Pune-based firm also manufactures and supplies various life-saving vaccines to EPI, UNICEF and different countries, Singh is learnt to have told the ministry.
"To fulfil our domestic and global supply commitments, we have to plan our production/cold chain space/human resource well in advance. In view of continuous increase in the stock of Covishield, we are facing a lot of difficulties in production/cold chain space/human resource planning for other life-saving vaccines," an official source quoted Singh as having stated in the letter.
"In view of these facts, genuine difficulties and as this matter is directly concerned with the availability of various other life-saving vaccines in our country and the world at large, we request for your kind intervention for fast-track movement of our Covishield vaccine domestically and globally," Singh is learnt to have stated.
The Centre has allowed SII to export 50 Lakh doses of Covishied under the UN-backed COVAX global vaccine sharing programme to Nepal, Tajikistan and Mozambique. SII will also export Covishield to Bangladesh under COVAX, an official source said.
The Serum Institute will commence its Covid vaccine export under the COVAX programme from November 23 and Nepal will receive the first lot of Covishiled on November 24.
The government had in October permitted SII to export 10 lakh Covishield doses, each to Nepal, Myanmar and Bangladesh under the 'Vaccine Maitri' programme.